Monica M Lahra, Rodney P Enriquez for the Australian Meningococcal Surveillance Programme
The reference laboratories of the National Neisseria Network, Australia report laboratory data on invasive meningococcal disease (IMD) cases confirmed by laboratory testing using culture and non-culture based techniques for the Australian Meningococcal Surveillance Programme (AMSP). Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification testing (NAAT) and serological techniques, are defined as IMD according to Public Health Laboratory Network definitions. Data contained in quarterly reports are usually restricted to a description of the numbers of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received. A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the AMSP annual reports published in Communicable Diseases Intelligence. For more information see Commun Dis Intell 2016;40(1):E179.
Of note in this quarter of 2016 is the number and proportion of IMD caused by serogroup W. This is particularly evident in New South Wales and Victoria, which have both shown substantial increases in both the number and proportion of serogroup W cases compared with previous years. In the years 2007–2011 the proportion of IMD caused by serogroup W in Australia ranged from 1.8% to 4.5%, and increased to 8.6% to 9.9% in 2013–2014. In 2015 this increased markedly to 31/81 (21.4%) IMD cases in Australia. In 2015 25 serogroup W IMD strains were genotyped, and 81% were sequence type (ST)-11, and had the porA antigen encoding gene type P1.5,2, the same genotype as the hypervirulent strain reported in the United Kingdom and South America since 2009. Nationally, enhanced surveillance strategies including whole genome sequencing and phylogenetic inference has been applied to the recent emergence of N. meningitidis serogroup W in Australia.
|State or territory||Year||Serogroup|
|Australian Capital Territory||2016||0||0||1||1||0||0||0||0||1||1||0||0||2||2|
|New South Wales||2016||0||0||8||18||0||1||6||9||13||22||1||3||28||53|
Monica M Lahra1,2
Rodney P Enriquez1
- Neisseria Reference Laboratory and World Health Organisation Collaborating Centre for STD, Sydney. Department of Microbiology, South Eastern Area Laboratory Services, The Prince of Wales Hospital, Randwick, New South Wales.
- School of Medical Sciences, Faculty of Medicine, The University of New South Wales, for the National Neisseria Network, New South Wales